Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,45009,1829,1.28 [1.16-1.42],1.2701335756916933e-06
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,44279,436,1.75 [1.46-2.10],1.1602930831574115e-09
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,49196,337,1.38 [1.11-1.72],0.0042101074970609
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,34009,1593,1.62 [1.46-1.80],4.249082477910241e-20
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,49087,228,1.32 [1.01-1.73],0.0436162674431253
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,45904,173,1.98 [1.51-2.59],6.642137334329221e-07
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51613,226,1.32 [1.01-1.73],0.0419493522276867
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51620,154,0.88 [0.61-1.27],0.4973434495629693
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44842,119,1.64 [1.15-2.35],0.006208600772887
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,49915,240,1.69 [1.33-2.14],1.7712017427453343e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,49829,154,1.86 [1.40-2.47],2.102615671297967e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51785,135,0.84 [0.56-1.25],0.3883006922070686
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51773,169,1.41 [1.04-1.92],0.0286424964122888
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51760,156,1.37 [0.99-1.89],0.0579328816177193
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,51070,106,1.03 [0.67-1.58],0.8800363089143051
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",49291,836,1.19 [1.03-1.38],0.020020403521821
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48741,286,1.26 [0.99-1.61],0.0655358287083869
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,49029,574,1.19 [1.00-1.42],0.0547122917167999
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",41516,132,1.40 [0.99-1.98],0.0545436000778782
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41497,113,0.93 [0.60-1.43],0.7288000620186201
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",41917,533,0.88 [0.72-1.08],0.2194044461636108
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",41934,550,0.88 [0.72-1.07],0.2000757657660694
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23480,678,1.19 [1.01-1.41],0.0403987001809713
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18819,237,0.72 [0.53-0.98],0.0385842737976832
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41489,105,0.82 [0.52-1.29],0.3818455135310483
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,46250,1613,1.35 [1.22-1.50],2.1072273121422652e-08
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",49188,674,1.12 [0.95-1.32],0.1768171895075959
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50853,236,1.07 [0.81-1.41],0.6528131147702212
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51940,225,1.37 [1.06-1.78],0.01673104745557
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,51375,135,1.21 [0.84-1.72],0.304245394431379
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51956,136,1.07 [0.74-1.55],0.732664324224203
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Stomach,52052,103,0.91 [0.58-1.43],0.6838389325132506
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,51496,599,1.05 [0.88-1.26],0.5763069595311183
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51962,220,0.97 [0.72-1.32],0.86376022249732
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51973,182,1.10 [0.80-1.52],0.5503150370295862
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51849,106,1.29 [0.86-1.93],0.2182474071420163
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma, any site",51854,105,1.25 [0.83-1.88],0.2862809411314559
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi,51683,400,0.85 [0.68-1.08],0.1776898431395555
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,51990,175,0.83 [0.58-1.18],0.2980380809386594
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Other benign neoplasms of skin,51778,370,1.20 [0.97-1.49],0.1005798731755252
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of breast,28000,138,0.96 [0.65-1.41],0.8394920911525092
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Leiomyoma of uterus,27481,1012,1.03 [0.89-1.18],0.7228805661261222
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49416,399,1.41 [1.15-1.73],0.000880580792174
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,48758,719,1.40 [1.20-1.63],1.7420892561203647e-05
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,48758,719,1.40 [1.20-1.63],1.7420892561203647e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),44936,940,1.52 [1.33-1.73],4.4014650353921007e-10
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50945,139,1.10 [0.76-1.59],0.6280356754543523
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51431,170,1.14 [0.82-1.57],0.4379088371610488
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,42051,2384,1.29 [1.18-1.41],1.9755683849779504e-08
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,48956,1096,1.12 [0.98-1.28],0.0987346466230446
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,47356,273,2.52 [2.08-3.07],1.7604504424794226e-20
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49644,226,1.88 [1.49-2.37],8.838594477302011e-08
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47327,244,2.42 [1.97-2.99],1.1415347186129942e-16
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,48206,1123,2.10 [1.87-2.35],5.628272184888628e-38
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,48170,1087,2.10 [1.87-2.36],2.908920845452675e-37
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,48148,376,1.22 [0.98-1.53],0.0799779050124573
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",48151,372,1.22 [0.97-1.53],0.0877626185702881
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,41700,2033,1.22 [1.10-1.34],8.867190451405539e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39934,267,1.45 [1.14-1.84],0.0024686365347921
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,41545,1878,1.18 [1.07-1.31],0.0015624019398717
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,39768,101,1.44 [0.97-2.14],0.069299520759446
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",39838,171,2.27 [1.78-2.90],4.954596494202026e-11
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Any mental disorder,44014,1328,1.09 [0.97-1.23],0.1506869447585331
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",43147,461,1.69 [1.41-2.02],1.4491627151947833e-08
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51233,344,1.84 [1.51-2.24],1.311104307621852e-09
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51366,249,1.82 [1.44-2.29],3.781000287771156e-07
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,48454,118,2.04 [1.48-2.82],1.5593247713125526e-05
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",51853,118,1.89 [1.38-2.60],8.118639973502906e-05
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",42804,118,2.02 [1.46-2.80],2.244346597020721e-05
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Alcohol dependence,48476,140,2.21 [1.66-2.95],6.638224742413228e-08
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Smoking dependency,48366,118,1.34 [0.92-1.96],0.1297467470272229
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42796,110,0.87 [0.56-1.36],0.5453343807756252
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",43352,666,0.98 [0.82-1.16],0.7769700179071658
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Depression,48802,583,0.94 [0.78-1.13],0.524387680228234
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Depression or dysthymia,42833,507,1.01 [0.83-1.24],0.8835733672787699
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",42945,259,0.93 [0.70-1.23],0.607908551365576
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Other anxiety disorders,49091,135,0.88 [0.59-1.29],0.5058332154599826
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Neurological diseases,44486,2999,1.17 [1.08-1.27],0.0001708584427387
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40384,271,0.90 [0.67-1.19],0.4454922482453876
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51749,214,0.76 [0.55-1.05],0.0906835597440356
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,49319,979,1.24 [1.09-1.42],0.0012242537514359
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Epilepsy,48648,308,1.37 [1.10-1.73],0.0059647423407098
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Migraine,48504,164,0.73 [0.51-1.07],0.104562191592137
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51436,148,0.75 [0.51-1.10],0.1407610376496144
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50359,161,1.22 [0.88-1.68],0.2385039715803751
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,48678,338,1.34 [1.08-1.65],0.0072531535060043
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,50879,258,1.37 [1.09-1.74],0.0082609082721798
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",49671,1357,1.12 [0.99-1.26],0.0621148207661987
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48562,248,0.83 [0.62-1.12],0.2186905355713532
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,49098,784,1.25 [1.08-1.45],0.0033298303712334
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51439,166,0.95 [0.67-1.34],0.7796122722796097
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hemiplegia,51389,116,1.04 [0.69-1.55],0.8609489121218047
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,51046,248,1.32 [1.02-1.70],0.0358457125875745
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50700,743,1.09 [0.93-1.28],0.2706924419477232
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50388,431,1.16 [0.95-1.43],0.1482177466340893
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,50110,153,1.15 [0.81-1.62],0.4258959011029291
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,50200,243,1.12 [0.85-1.47],0.429947437407999
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,50113,156,1.06 [0.75-1.51],0.7383253288852979
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,44811,327,1.45 [1.16-1.80],0.000998742661623
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,45290,806,1.48 [1.28-1.70],5.707572840890134e-08
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,50005,441,1.40 [1.16-1.70],0.0004683789602983
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51372,106,2.14 [1.57-2.93],1.6991588932781297e-06
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4438,106,1.52 [1.10-2.09],0.010869113561118
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",47040,106,2.43 [1.77-3.34],3.836592108578725e-08
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50664,190,1.32 [0.98-1.77],0.065058528928467
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,50579,105,1.20 [0.80-1.80],0.3868498663829905
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50635,176,0.93 [0.66-1.31],0.6787919950744312
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,50933,201,0.99 [0.72-1.35],0.9442429135788434
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,51829,270,0.78 [0.59-1.04],0.0884649901760205
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,50274,202,0.85 [0.62-1.18],0.3316976114549271
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,36827,6634,1.44 [1.35-1.53],4.573333586131478e-28
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50757,136,2.30 [1.75-3.02],1.869308674959611e-09
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",38778,4578,1.34 [1.25-1.45],2.2451466560635005e-15
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertension,38847,4647,1.35 [1.25-1.45],7.469252885428491e-16
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34363,163,2.10 [1.60-2.75],1.0626094464212085e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",47592,2425,1.24 [1.13-1.36],2.2709805384274385e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,46622,1455,1.17 [1.04-1.31],0.0069041707112728
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49921,492,1.21 [1.01-1.46],0.0390424591175795
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50398,969,1.11 [0.97-1.28],0.1290873318197071
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51774,193,1.03 [0.76-1.41],0.8305667641337879
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45768,601,1.15 [0.96-1.37],0.1243336742447804
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,47060,1929,1.25 [1.13-1.38],8.43990781693743e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50366,221,1.32 [1.01-1.73],0.0415145805072369
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,50578,462,1.22 [1.01-1.48],0.0386595808372308
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50325,180,2.50 [1.99-3.14],2.8119348171732024e-15
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50327,182,2.48 [1.97-3.11],4.735996547315903e-15
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34374,174,2.61 [2.06-3.31],1.6693691567889534e-15
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,43126,118,2.55 [1.93-3.37],4.323261265393832e-11
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,43256,248,1.85 [1.47-2.32],1.312957611627871e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28699,241,1.71 [1.33-2.20],2.9627836558544675e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,29345,887,2.81 [2.48-3.20],7.633286852799069e-57
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,43144,136,2.14 [1.61-2.85],1.6872929010007e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,43195,187,2.40 [1.91-3.00],3.4971307175543563e-14
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",49867,417,2.34 [2.00-2.73],1.8489533120679024e-26
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50211,317,1.18 [0.94-1.50],0.1567737863356073
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",50280,267,1.28 [1.00-1.64],0.0494466100678405
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",50434,236,1.27 [0.98-1.66],0.071308830271294
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49642,161,1.24 [0.89-1.71],0.1978589566523926
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49743,262,1.47 [1.16-1.87],0.0014847711786844
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),49054,285,1.19 [0.93-1.53],0.1708215258685791
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,49011,242,1.26 [0.97-1.64],0.0859468443639974
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51601,231,1.20 [0.92-1.57],0.174232967551662
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Varicose veins,49731,962,1.01 [0.87-1.16],0.9352173868046796
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypotension,49593,177,1.61 [1.21-2.14],0.001071805654213
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,41487,4163,1.27 [1.18-1.36],4.6501013317014195e-11
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51661,219,1.06 [0.79-1.42],0.7036652357537703
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,48228,453,1.66 [1.39-1.98],1.7286486242941036e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",48171,396,1.71 [1.42-2.06],1.3354015655069422e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50135,508,1.48 [1.25-1.76],6.065972425653873e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50124,497,1.48 [1.24-1.76],8.948819477889548e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50412,1234,0.96 [0.84-1.09],0.5302937110816024
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,49368,190,0.96 [0.69-1.33],0.8116296023838585
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Nasal polyp,49429,251,1.12 [0.85-1.46],0.4153158562727017
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49972,794,0.97 [0.83-1.13],0.6852890978025936
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,49551,373,1.02 [0.81-1.28],0.8523764332777677
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23926,126,0.89 [0.58-1.36],0.590816662994017
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,46479,2045,1.30 [1.18-1.42],6.544453757180841e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Early onset COPD,49642,356,1.72 [1.42-2.09],4.737792462118888e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",49695,409,1.78 [1.49-2.14],2.9906905881628436e-10
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",49695,409,1.78 [1.49-2.14],2.9906905881628436e-10
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",48521,1689,1.21 [1.09-1.35],0.0002627506112655
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Asthma,37145,1689,1.28 [1.15-1.43],4.80434002969378e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",36600,1689,1.30 [1.17-1.45],1.522016868725547e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",37120,1664,1.29 [1.16-1.43],3.982038144813595e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51282,182,1.48 [1.11-1.97],0.0073201694387205
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,49035,140,1.40 [1.00-1.95],0.0500410485178381
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",51442,140,1.40 [1.00-1.95],0.0491432379215446
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49021,126,1.36 [0.95-1.94],0.0910531448562553
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural effusion,47826,223,1.71 [1.34-2.18],1.7565471417375085e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,48085,482,1.71 [1.44-2.02],5.007118678258005e-10
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,49482,221,1.86 [1.47-2.35],1.8860848369313428e-07
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,35372,11765,1.01 [0.96-1.06],0.6871475062465127
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50972,847,1.26 [1.09-1.46],0.001436592667584
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51977,186,1.17 [0.86-1.61],0.3191003457010485
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impacted teeth,51985,172,1.15 [0.83-1.60],0.3905285099527068
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Dental caries,50342,217,1.35 [1.03-1.78],0.0305921581386511
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,50326,201,1.32 [0.99-1.77],0.0569000768681019
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51958,206,1.11 [0.82-1.50],0.5110513078747008
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,50322,197,1.19 [0.88-1.60],0.266644579551093
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49784,158,1.03 [0.73-1.46],0.8693196060717993
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51813,106,0.93 [0.60-1.44],0.732938004652103
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39553,553,1.03 [0.85-1.25],0.7589664163796302
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",43374,4374,0.97 [0.90-1.04],0.4242111838785883
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophagitis,39686,686,0.97 [0.82-1.16],0.7434104956944783
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,40405,1405,0.85 [0.75-0.97],0.0122121536540199
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39154,154,1.54 [1.12-2.11],0.0077324875783397
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39415,415,1.11 [0.90-1.38],0.3269248723051647
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,39116,116,0.78 [0.50-1.21],0.2706567299497969
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,39310,310,1.12 [0.87-1.43],0.386720563850042
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,39252,252,0.96 [0.73-1.28],0.8064281068981717
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51767,175,0.88 [0.63-1.24],0.4625159119213099
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,39252,252,1.02 [0.77-1.35],0.9141049330424592
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),40648,1648,1.02 [0.91-1.14],0.7554300032102883
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,51720,255,0.84 [0.63-1.12],0.2393390406921497
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,39880,880,0.95 [0.81-1.11],0.5056722096490898
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,39344,344,0.97 [0.76-1.25],0.8367356222886442
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51716,314,1.14 [0.90-1.45],0.2743554143730362
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,51670,205,0.91 [0.67-1.26],0.5802430447516868
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Hernia,45558,3298,0.92 [0.85-1.00],0.0530344309604556
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,43467,1207,0.95 [0.83-1.09],0.4765154086397308
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,42520,260,1.13 [0.88-1.46],0.3375779000388856
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ventral hernia,42466,206,1.48 [1.14-1.93],0.003510418309712
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,44016,1756,0.84 [0.75-0.93],0.0017028533393441
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50065,1530,1.24 [1.11-1.38],0.0001283511375889
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,40718,4062,1.09 [1.02-1.18],0.01421932132071
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",51353,119,1.64 [1.17-2.31],0.0045943727560394
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",51902,164,1.74 [1.31-2.31],0.0001475295683006
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn disease,48699,164,1.76 [1.32-2.34],0.0001137073748634
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48659,124,1.85 [1.35-2.56],0.0001599560178717
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",51766,276,1.42 [1.12-1.80],0.0037679808588468
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,48811,276,1.44 [1.13-1.82],0.0028159173297477
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48783,248,1.46 [1.14-1.87],0.0028760365631449
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49777,1242,1.18 [1.05-1.33],0.0071304918087962
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49763,1228,1.18 [1.04-1.33],0.008724250538512
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36857,201,1.05 [0.77-1.43],0.7695402761445405
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal stricture,51102,201,1.04 [0.76-1.42],0.7973748483296992
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36788,132,1.18 [0.82-1.71],0.3724939038842632
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,37882,1226,1.07 [0.95-1.22],0.2708778003240383
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36994,338,1.04 [0.82-1.33],0.7459316686059868
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,37240,584,1.20 [1.00-1.43],0.0494595722611218
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Constipation,48713,524,1.19 [0.99-1.44],0.0634661776417252
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51124,179,1.04 [0.75-1.43],0.8342109231040631
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36943,287,1.04 [0.80-1.34],0.791973635080405
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36801,145,1.11 [0.78-1.58],0.5647628814355918
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38438,1782,1.09 [0.98-1.21],0.1159523448076234
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,37209,553,1.33 [1.12-1.58],0.0012712527019477
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51095,150,0.97 [0.67-1.39],0.8613350876624075
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of liver,50383,252,3.44 [2.90-4.10],2.235089958262776e-44
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,50269,138,3.18 [2.52-4.01],1.6211663243773441e-22
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49266,1275,1.10 [0.97-1.24],0.1232717705878444
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,49014,1023,0.94 [0.81-1.08],0.3917792478681368
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholecystitis,48195,204,1.39 [1.06-1.84],0.0191576189107734
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48096,105,1.59 [1.10-2.31],0.0138384925226731
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,48130,139,1.45 [1.04-2.01],0.0272043343692162
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),51684,139,1.44 [1.04-1.99],0.0285417328748578
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,49229,634,1.12 [0.94-1.32],0.2085777233811198
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48739,144,0.53 [0.35-0.80],0.0023834689735557
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Coeliac disease,48713,118,0.48 [0.30-0.76],0.0016894072213788
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48695,100,1.39 [0.94-2.07],0.0997904890305391
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,48996,401,1.27 [1.03-1.56],0.0227034078515931
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,GI-bleeding,48982,387,1.29 [1.04-1.58],0.0178293043497272
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,45626,3148,1.15 [1.06-1.25],0.0006353058790692
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51116,210,1.19 [0.89-1.59],0.2300207473333488
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,51186,919,0.97 [0.84-1.12],0.676838176086684
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,48804,1174,1.16 [1.02-1.32],0.0199221790375681
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,50177,795,1.19 [1.02-1.38],0.0251648693483588
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49560,178,1.12 [0.81-1.54],0.4854629235137744
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49891,509,1.27 [1.06-1.52],0.0096644777453233
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51468,186,1.51 [1.14-1.99],0.0038988691856725
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51425,143,1.62 [1.19-2.20],0.001959803645534
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51392,110,1.92 [1.39-2.65],6.937765155871731e-05
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51434,115,1.04 [0.69-1.57],0.8450054939522825
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51429,110,1.03 [0.68-1.57],0.8860965415326123
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,50380,113,0.77 [0.50-1.19],0.2322925548119285
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,51002,735,0.99 [0.84-1.17],0.9276702501408852
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47820,190,1.23 [0.90-1.67],0.1889802188465151
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47836,206,1.21 [0.90-1.63],0.2096629884000102
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47787,157,1.12 [0.79-1.59],0.5232032468697416
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48077,447,1.14 [0.93-1.40],0.2081104625678621
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48031,401,1.16 [0.93-1.44],0.1822444838992408
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37451,8064,1.00 [0.95-1.06],0.917651682414195
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40716,4687,1.03 [0.96-1.11],0.3809770135113876
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,46901,2445,1.04 [0.95-1.14],0.3982296517026178
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36335,306,1.25 [0.99-1.59],0.0659128332361805
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,36967,938,1.16 [1.01-1.34],0.0357551937929217
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51180,294,1.25 [0.98-1.59],0.0752579277119025
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51202,266,1.34 [1.05-1.72],0.0204012406687348
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,38356,2327,0.94 [0.86-1.04],0.25998460933553
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",43568,2327,0.92 [0.83-1.01],0.0745290476126176
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36170,141,1.58 [1.16-2.16],0.0039196215254825
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50863,137,1.58 [1.17-2.15],0.0031620736689339
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,36477,448,0.97 [0.78-1.20],0.7917472715159073
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36175,146,1.09 [0.77-1.56],0.6227281118446005
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,36596,567,0.93 [0.77-1.13],0.4581770222651914
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51708,279,1.05 [0.81-1.36],0.7272939930238944
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,37101,1072,0.95 [0.82-1.09],0.4631150900957297
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,36831,802,0.98 [0.83-1.15],0.8072949978838355
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,38638,2609,1.06 [0.97-1.16],0.2123806545980173
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),36160,131,1.16 [0.79-1.69],0.4479882961128989
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36505,476,0.85 [0.69-1.06],0.1551455654284142
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,36142,113,1.06 [0.70-1.61],0.7862735238988299
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),36151,122,0.60 [0.38-0.95],0.0288562744494182
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,37012,983,1.11 [0.97-1.28],0.1433977601904632
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36879,850,1.10 [0.95-1.28],0.2160133191305662
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40269,563,0.98 [0.81-1.19],0.8484075972216891
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50906,258,0.67 [0.49-0.90],0.0083233075545998
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50760,112,0.84 [0.54-1.31],0.4434705704478839
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44970,127,1.20 [0.83-1.75],0.3325940285838521
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,45444,601,0.96 [0.80-1.16],0.6782623331050479
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,46727,1884,0.91 [0.81-1.01],0.0683325613117808
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,45227,384,0.82 [0.65-1.04],0.099509534003257
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45017,174,1.15 [0.84-1.59],0.3844318930548405
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",46326,1483,0.90 [0.79-1.01],0.0734280033258893
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44945,102,1.14 [0.75-1.73],0.5325341616616908
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,45321,478,0.92 [0.74-1.13],0.4118230114819531
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,45049,206,0.88 [0.64-1.21],0.4294768609329015
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,45003,160,0.96 [0.68-1.37],0.8340749838702932
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45127,284,0.99 [0.76-1.29],0.9265618953808724
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44972,129,1.01 [0.69-1.50],0.9489311626308102
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45466,623,0.73 [0.61-0.89],0.0015016562051873
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45087,631,1.12 [0.94-1.33],0.2029492973795722
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44596,140,1.11 [0.77-1.59],0.5869261429226257
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44631,175,1.27 [0.93-1.73],0.1325110160620176
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44663,207,0.88 [0.64-1.21],0.4316392167770962
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44556,100,1.18 [0.78-1.79],0.4396156641826961
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44689,233,0.81 [0.59-1.10],0.1732235872901893
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44662,206,0.83 [0.60-1.15],0.2557771588077265
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44989,533,0.94 [0.78-1.15],0.5552130212516198
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44566,110,0.91 [0.59-1.41],0.6822721906528482
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44613,157,0.81 [0.56-1.17],0.2651200973676044
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44712,256,0.84 [0.63-1.13],0.2480796883243409
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44582,126,1.09 [0.74-1.60],0.6579066518430461
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45359,903,1.11 [0.96-1.28],0.1497983326892754
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44796,340,1.36 [1.09-1.68],0.0053603097993155
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44940,484,1.14 [0.94-1.39],0.1763521377207707
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,48205,345,0.93 [0.73-1.19],0.5810415759050562
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,48648,788,1.02 [0.87-1.19],0.8230371235580668
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47959,99,1.03 [0.66-1.59],0.9031956960930284
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47978,118,0.86 [0.56-1.32],0.4909382044166694
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,48067,207,1.00 [0.73-1.37],0.9934406323236962
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,41274,8622,1.01 [0.95-1.06],0.8178188779850171
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20660,1296,0.92 [0.81-1.05],0.23009166898964
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,46698,512,1.45 [1.22-1.73],3.569345568637193e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46325,139,1.24 [0.87-1.77],0.226006640137513
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,46907,109,1.47 [1.01-2.13],0.0435926388109784
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,46941,143,1.87 [1.40-2.51],2.3010153469589103e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46931,133,1.87 [1.38-2.53],4.74326701171818e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51284,502,1.30 [1.09-1.56],0.0039150466831899
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51125,146,2.04 [1.55-2.66],2.3329725824555245e-07
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,51142,360,1.29 [1.04-1.59],0.0195612389958433
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50957,175,1.32 [0.98-1.78],0.0707997628756414
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,47521,2117,0.97 [0.88-1.07],0.53822060415334
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,45603,199,1.22 [0.91-1.66],0.1875103469362806
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45566,162,1.15 [0.82-1.62],0.4093455493312481
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45963,559,0.93 [0.77-1.13],0.465684174626824
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45636,232,1.09 [0.82-1.45],0.5651758662782022
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,46778,1374,0.98 [0.86-1.11],0.7251569511019973
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19938,574,0.90 [0.74-1.10],0.3059348491499839
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19471,107,0.63 [0.39-1.01],0.0566162669409974
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19466,102,1.10 [0.73-1.67],0.6407594877161669
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19529,165,1.32 [0.97-1.78],0.0782567086159102
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19527,163,0.75 [0.52-1.08],0.1271888270127631
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19581,217,1.00 [0.75-1.35],0.974031068892142
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27736,485,0.98 [0.80-1.21],0.858673923176545
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27401,150,0.91 [0.62-1.33],0.6235441553435974
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27422,171,0.96 [0.68-1.36],0.8121053736244891
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27364,113,1.04 [0.69-1.59],0.8411200305898944
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27673,565,0.79 [0.65-0.97],0.0223722500850873
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,27242,134,0.78 [0.52-1.18],0.2349233231730429
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27360,252,0.84 [0.63-1.13],0.2492200436918201
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25573,4660,0.93 [0.86-1.00],0.0395302326264173
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,21280,367,0.81 [0.63-1.03],0.0884497999052524
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,21011,98,0.75 [0.47-1.20],0.2276869278040886
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21083,170,0.60 [0.41-0.87],0.0066600268327037
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21719,806,0.66 [0.56-0.79],5.216863968963422e-06
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21330,417,0.79 [0.62-0.99],0.0422077511886206
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21887,974,1.01 [0.87-1.18],0.8534615523415061
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21234,321,0.99 [0.77-1.27],0.9228709397119766
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21359,446,1.06 [0.86-1.31],0.5797377374845253
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,21014,101,0.81 [0.51-1.29],0.3752884964143834
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,21104,191,0.76 [0.54-1.07],0.1191750703412865
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",28013,270,0.91 [0.69-1.20],0.5058331363764439
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,28025,256,0.92 [0.69-1.23],0.5895662695695718
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,28051,142,1.06 [0.73-1.54],0.7485440719189241
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",28040,156,1.02 [0.71-1.46],0.9055106464349372
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21061,148,0.98 [0.67-1.42],0.8955109026427713
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,21028,115,1.07 [0.71-1.63],0.7365597995088207
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21058,145,1.24 [0.87-1.77],0.2293556951870381
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27942,474,1.01 [0.82-1.25],0.899511981323136
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22277,1364,0.99 [0.87-1.12],0.8551892413048279
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21803,890,0.97 [0.83-1.14],0.7387875285024397
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",28030,197,1.07 [0.78-1.47],0.6565959838879751
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21387,474,0.88 [0.71-1.09],0.2451238717518437
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21247,334,0.88 [0.68-1.13],0.3152087244395216
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21821,908,1.21 [1.04-1.40],0.0131189536469251
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female infertility,21028,115,1.10 [0.73-1.67],0.6440038727758073
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",21021,108,1.11 [0.73-1.70],0.6306641750894577
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,28047,888,0.88 [0.75-1.05],0.1505638907651458
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,28050,1214,0.92 [0.79-1.06],0.245421528985682
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,28048,487,0.92 [0.75-1.14],0.450862138151083
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27699,138,0.84 [0.57-1.24],0.376567644179109
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27756,195,1.00 [0.73-1.39],0.9858870841594072
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27731,170,0.90 [0.64-1.28],0.5637112114305811
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",28066,168,1.06 [0.75-1.50],0.7597653224517043
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,28068,165,1.04 [0.73-1.48],0.8301932591479202
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,28066,423,0.98 [0.78-1.23],0.8384457717906479
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27770,127,0.99 [0.66-1.47],0.9566124156671828
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27876,233,0.96 [0.71-1.30],0.7908461168754121
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27308,149,0.68 [0.46-1.00],0.0485617450149414
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27362,203,1.05 [0.77-1.45],0.7457363390456424
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27412,253,0.92 [0.69-1.24],0.5955873431385542
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27307,148,0.74 [0.50-1.10],0.1334538639192438
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27299,140,0.61 [0.41-0.92],0.0174991828520297
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27312,153,0.91 [0.63-1.32],0.627920177129542
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,27071,235,0.83 [0.61-1.13],0.2312035244895071
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],27280,444,0.90 [0.72-1.13],0.3616984334115111
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27515,679,0.94 [0.78-1.14],0.5315748157207469
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",28069,173,1.50 [1.09-2.07],0.0126041365562818
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26594,132,1.57 [1.09-2.24],0.0140003386023903
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26939,103,1.17 [0.76-1.80],0.4825093024589046
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,28078,346,0.88 [0.69-1.13],0.331197465826361
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27996,264,0.86 [0.65-1.14],0.2956273668489636
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",28064,257,0.78 [0.58-1.04],0.0897890878377229
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",28054,247,0.75 [0.56-1.02],0.0663869876887099
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51236,124,1.35 [0.95-1.93],0.0967216526772939
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,46893,1211,1.19 [1.05-1.34],0.0065069988205382
